112 related articles for article (PubMed ID: 16713570)
21. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
[TBL] [Abstract][Full Text] [Related]
22. VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing.
Santos SC; Miguel C; Domingues I; Calado A; Zhu Z; Wu Y; Dias S
Exp Cell Res; 2007 May; 313(8):1561-74. PubMed ID: 17382929
[TBL] [Abstract][Full Text] [Related]
23. Functions of heparan sulfate proteoglycans in cell signaling during development.
Lin X
Development; 2004 Dec; 131(24):6009-21. PubMed ID: 15563523
[TBL] [Abstract][Full Text] [Related]
24. VEGF receptor signalling - in control of vascular function.
Olsson AK; Dimberg A; Kreuger J; Claesson-Welsh L
Nat Rev Mol Cell Biol; 2006 May; 7(5):359-71. PubMed ID: 16633338
[TBL] [Abstract][Full Text] [Related]
25. Shedding light on the distinct functions of proteoglycans.
Selleck SB
Sci STKE; 2006 Apr; 2006(329):pe17. PubMed ID: 16595733
[TBL] [Abstract][Full Text] [Related]
26. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
[TBL] [Abstract][Full Text] [Related]
27. VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle.
Mac Gabhann F; Ji JW; Popel AS
J Appl Physiol (1985); 2007 Feb; 102(2):722-34. PubMed ID: 17038488
[TBL] [Abstract][Full Text] [Related]
28. Assessment of VEGF-receptor system expression in the porcine endometrial stromal cells in response to insulin-like growth factor-I, relaxin, oxytocin and prostaglandin E2.
Kaczmarek MM; Blitek A; Kaminska K; Bodek G; Zygmunt M; Schams D; Ziecik AJ
Mol Cell Endocrinol; 2008 Sep; 291(1-2):33-41. PubMed ID: 18562087
[TBL] [Abstract][Full Text] [Related]
29. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.
Wilkinson L; Gilbert T; Kinna G; Ruta LA; Pennisi D; Kett M; Little MH
J Am Soc Nephrol; 2007 Jun; 18(6):1697-708. PubMed ID: 17460146
[TBL] [Abstract][Full Text] [Related]
30. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
Tammela T; He Y; Lyytikkä J; Jeltsch M; Markkanen J; Pajusola K; Ylä-Herttuala S; Alitalo K
Circ Res; 2007 May; 100(10):1468-75. PubMed ID: 17478733
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor signaling to endothelial nitric oxide synthase: more than a FLeeTing moment.
Lin MI; Sessa WC
Circ Res; 2006 Sep; 99(7):666-8. PubMed ID: 17008595
[No Abstract] [Full Text] [Related]
32. Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells.
Palmieri D; Astigiano S; Barbieri O; Ferrari N; Marchisio S; Ulivi V; Volta C; Manduca P
Exp Cell Res; 2008 Jul; 314(11-12):2289-98. PubMed ID: 18570923
[TBL] [Abstract][Full Text] [Related]
33. Substrate matters: reciprocally stimulatory integrin and VEGF signaling in endothelial cells.
Brakenhielm E
Circ Res; 2007 Sep; 101(6):536-8. PubMed ID: 17872470
[No Abstract] [Full Text] [Related]
34. Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy.
Mac Gabhann F; Ji JW; Popel AS
PLoS Comput Biol; 2006 Sep; 2(9):e127. PubMed ID: 17002494
[TBL] [Abstract][Full Text] [Related]
35. VEGF-receptor signal transduction.
Cross MJ; Dixelius J; Matsumoto T; Claesson-Welsh L
Trends Biochem Sci; 2003 Sep; 28(9):488-94. PubMed ID: 13678960
[TBL] [Abstract][Full Text] [Related]
36. The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.
Beckouche N; Bignon M; Lelarge V; Mathivet T; Pichol-Thievend C; Berndt S; Hardouin J; Garand M; Ardidie-Robouant C; Barret A; Melino G; Lortat-Jacob H; Muller L; Monnot C; Germain S
Sci Signal; 2015 Jul; 8(385):ra70. PubMed ID: 26175493
[TBL] [Abstract][Full Text] [Related]
37. Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling.
Grünewald FS; Prota AE; Giese A; Ballmer-Hofer K
Biochim Biophys Acta; 2010 Mar; 1804(3):567-80. PubMed ID: 19761875
[TBL] [Abstract][Full Text] [Related]
38. From the Editors' desk.
Olsen B
Matrix Biol; 2004 Nov; 23(7):417-9. PubMed ID: 15579308
[No Abstract] [Full Text] [Related]
39. Monte Carlo simulations of VEGF binding to cell surface receptors in vitro.
Mac Gabhann F; Yang MT; Popel AS
Biochim Biophys Acta; 2005 Dec; 1746(2):95-107. PubMed ID: 16257459
[TBL] [Abstract][Full Text] [Related]
40. [Heparan sulfate proteoglycans mediating the epithelial and mesenchymal interaction].
Habuchi H; Kimata K
Seikagaku; 2001 Oct; 73(10):1246-56. PubMed ID: 11725542
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
